GLYCOMIMETICS INC (GLYC) [Rocket]

Date Filed	Type	Description
01/07/2021	GN	APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
11/06/2018	GN	Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP — Future Expectations, Projections Moving into 2018
07/27/2018	GN	Factors of Influence in 2018, Key Indicators and Opportunity within Minerals Technologies, USG, Continental Resources, Take-Two Interactive Software, Trimble, and GlycoMimetics — New Research Emphasizes Economic Growth
05/22/2018	GN	New Research Coverage Highlights Apollo Commercial Real Estate Finance, Drive Shack, GlycoMimetics, Dycom Industries, Apple Hospitality REIT, and Howard Hughes — Consolidated Revenues, Company Growth, and Expectations for 2018
05/03/2018	BW	GlycoMimetics Reports First Quarter 2018 Results
04/26/2018	BW	GlycoMimetics to Report First Quarter 2018 Financial Results on May 3, 2018
03/06/2018	BW	GlycoMimetics Reports Fourth Quarter and Year-End 2017 Results
02/27/2018	BW	GlycoMimetics to Report Fourth Quarter and Year-End 2017 Financial Results on March 6, 2018
01/26/2018	GN	New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained Production
12/12/2017	BW	GlycoMimetics Reports Improvements in Median Overall Survival Versus Historical Matched Controls for Two AML Patient Subgroups in Phase 1/2 Trial for GMI-1271
11/09/2017	BW	GlycoMimetics to Present at Upcoming Healthcare Investor Conferences